Literature DB >> 29789225

Grafting for bone defects after curettage of benign bone tumor - Analysis of factors influencing the bone healing.

Po-Kuei Wu1, Cheng-Fong Chen2, Chao-Ming Chen3, Shang-Wen Tsai3, Yu-Chi Cheng4, Ming-Chau Chang1, Wei-Ming Chen5.   

Abstract

BACKGROUND: Simple bone cyst often weaken bone properties and predispose to pathological fractures, requiring tumor excision and the filling of bone defects with grafts to prevent complications. The purpose of this study was to evaluate factors potentially affecting the quality and efficiency of graft healing.
METHODS: This study retrospectively assessed 84 patients with simple bone cysts who had undergone tumor excision and filling of the bone defects with grafts between 2004 and 2014. Various patient-, tumor- and treatment-related factors that could potentially influence radiologic healing status and time to stable healing were evaluated.
RESULTS: Bone healing was not related to gender and age. Graft type was not significantly correlated with both radiologic healing status or time to stable healing. Only two of all variables evaluated were significantly correlated with the prognosis: (1) Tumors location: patients with tumors located at proximal femur were significantly more likely to achieve complete healing (Neer I) (OR = 3.2; 95%CI, 1.29-8.00; p = 0.011). (2) Tumor length: patients with a tumor length less than 6.2 cm, complete healing was nearly five times more likely to occur (OR = 4.84; 95% CI, 1.83-12.84; p = 0.002). Degree of graft filling of the bone defects affected the time to stable healing. The average healing times were 4.86 months for filling degree ≥90% and 5.94 months for filling degrees <90%, respectively (p = 0.009). Postoperative re-fracture occurred in one case.
CONCLUSION: Factors influencing the quality of bone healing following intralesional curettage and bone grafting are proximal femur location and tumor length. A greater degree of graft filling can contribute to higher bone healing efficiency.
Copyright © 2018. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  Benign bone tumor; Bone grafts; Bone healing; Bone substitute

Mesh:

Year:  2018        PMID: 29789225     DOI: 10.1016/j.jcma.2017.08.024

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  5 in total

1.  The minimally invasive endoscopic technique for the treatment of symptomatic benign bone lesions: Preliminary results from a retrospective study.

Authors:  Min-Hao Wu; Ling-Fei Xiao; Chong Zhang; Jun Lei; Zhou-Ming Deng
Journal:  J Bone Oncol       Date:  2020-08-02       Impact factor: 4.072

2.  Application of osteoinductive calcium phosphate ceramics in giant cell tumor of the sacrum: report of six cases.

Authors:  Yitian Wang; Xiangfeng Li; Yi Luo; Li Zhang; Hezhong Chen; Li Min; Qing Chang; Yong Zhou; Chongqi Tu; Xiangdong Zhu; Xingdong Zhang
Journal:  Regen Biomater       Date:  2022-04-11

Review 3.  Surgical Classification for Preclinical Rat Femoral Bone Defect Model: Standardization Based on Systematic Review, Anatomical Analysis and Virtual Surgery.

Authors:  Yu Sun; Heike Helmholz; Regine Willumeit-Römer
Journal:  Bioengineering (Basel)       Date:  2022-09-15

4.  A clinical trial of a unidirectional porous tricalcium phosphate filling for defects after resection of benign bone lesions: a prospective multicenter study.

Authors:  Kunihiro Ikuta; Yoshihiro Nishida; Takehiro Ota; Satoshi Tsukushi; Eiji Kozawa; Hiroatsu Nakashima; Kenji Yamada; Satoshi Yamashita; Shiro Imagama
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

5.  A Preliminary Study on the Mechanical Reliability and Regeneration Capability of Artificial Bone Grafts in Oncologic Cases, With and Without Osteosynthesis.

Authors:  Michele Boffano; Nicola Ratto; Andrea Conti; Pietro Pellegrino; Laura Rossi; Giuseppe Perale; Raimondo Piana
Journal:  J Clin Med       Date:  2020-05-08       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.